Related content

Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth

By Lam Thomas   Hetherington John   Greenman John   Little Samantha   Maraveyas Anthony  

Acta Oncologica, Vol. 46, Iss. 8, 2007-01 ,pp. : 1169-1177

Informa Healthcare

Access to resources Recommend Favorite

Anticancer activity of bicalutamide-loaded PLGA nanoparticles in prostate cancers

By Guo Jun   Wu ShuHong   Ren WeiGuo   Wang XinLi   Yang AiQing  

Experimental and Therapeutic Medicine, Vol. 10, Iss. 6, 2015-12 ,pp. : 2305-2310

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of SSG and SSG/IFNα2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action

By Li Jing   Lindner Daniel   Farver Carol   Borden Ernest   Yi Taolin  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 341-349

Springer Publishing Company

Access to resources Recommend Favorite

Effects of a human compact anti-ErbB2 antibody on prostate cancer

By              

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 297-302

Spandidos Publications

Access to resources Recommend Favorite

Significant systemic therapeutic effects of high-LET immunoradiation by 212Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice

By                  

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1881-1888

Spandidos Publications

Access to resources Recommend Favorite